Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1999 Sep;25(9):1286-8.
doi: 10.1016/s0886-3350(99)00159-5.

Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone

T Abe  1 , S Hayasaka, Y Nagaki, C Kadoi, M Matsumoto, Y Hayasaka
Affiliations
Case Reports

Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone

T Abe et al. J Cataract Refract Surg. 1999 Sep.

Abstract

Purpose: To evaluate the efficacy of high-dose methylprednisolone in the treatment of pseudophakic cystoid macular edema (CME).

Setting: University-affiliated hospital.

Methods: Four patients with pseudophakic CME who reported decreased visual acuities were treated with oral prednisolone (20 mg daily for 5 days), oral acetazolamide (500 mg daily for 5 days), and topical dexamethasone 0.1% and diclofenac 0.1% (4 times a day for 14 days). The CME did not resolve. Next, they were treated with high-dose (1000 mg daily) intravenous methylprednisolone for 3 days.

Results: In 3 of 4 eyes, the CME resolved and visual acuity improved.

Conclusion: High-dose methylprednisolone may be effective in the treatment of pseudophakic CME.

PubMed Disclaimer

Publication types

MeSH terms